Skip to main content
. 2020 May 23;21(10):3682. doi: 10.3390/ijms21103682

Figure 2.

Figure 2

Secreted PCSK9 binds to LDLR on the liver surface and mediates the lysosomal degradation of the complex formed by PCK9-LDLR, leading to decreased density of LDLR on the hepatocyte surface and further to increased LDL level in serum. Abbreviations: LDL—low-density lipoprotein; PCSK9—proprotein convertase subtilisin/kexin type 9; LDLR—low-density lipoprotein receptor.